Gender-differences in antithrombotic therapy across the spectrum of ischemic heart disease: Time to tackle the Yentl syndrome?

The incidence and clinical presentation of ischemic heart disease (IHD), as well as thrombotic and bleeding risks, appear to differ between genders. Compared with men, women feature an increased thrombotic risk, probably related to an increased platelet reactivity, higher level of coagulation factor...

Descripción completa

Detalles Bibliográficos
Autores principales: Laborante, Renzo, Borovac, Josip Andjelo, Galli, Mattia, Rodolico, Daniele, Ciliberti, Giuseppe, Restivo, Attilio, Cappannoli, Luigi, Arcudi, Alessandra, Vergallo, Rocco, Zito, Andrea, Princi, Giuseppe, Leone, Antonio Maria, Aurigemma, Cristina, Romagnoli, Enrico, Montone, Rocco Antonio, Burzotta, Francesco, Trani, Carlo, D’Amario, Domenico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659635/
https://www.ncbi.nlm.nih.gov/pubmed/36386309
http://dx.doi.org/10.3389/fcvm.2022.1009475

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659635/
https://www.ncbi.nlm.nih.gov/pubmed/36386309
http://dx.doi.org/10.3389/fcvm.2022.1009475

Ejemplares similares